Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
184,457
clinical trials

Advanced Solid Neoplasms Clinical Trial
A Study of Safety, Pharmacokinetics and Pharmacodynamics of JNJ-64457107 in Participants With Advanced Stage Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
2122
mi
from 91732
Pittsburgh, PA
Click here to add this to my saved trials
Advanced Solid Neoplasms Clinical Trial
A Study of Safety, Pharmacokinetics and Pharmacodynamics of JNJ-64457107 in Participants With Advanced Stage Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
572
mi
from 91732
Salt Lake City, UT
Click here to add this to my saved trials
Chronic Kidney Disease Clinical Trial
Senescence in Chronic Kidney Disease
Status: Enrolling, Phase II
Updated: 12/31/1969
1524
mi
from 91732
Rochester, MN
Click here to add this to my saved trials
Autism Spectrum Disorders Clinical Trial
Single Dose Intranasal Oxytocin and Cognitive Effects in Autism
Status: Enrolling, Phase II
Updated: 12/31/1969
1510
mi
from 91732
Minneapolis, MN
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Study of Azacitidine in Combination With Pembrolizumab in Relapsed/Refractory Acute Myeloid Leukemia (AML) Patients and in Newly Diagnosed Older (≥65 Years) AML Patients
Status: Enrolling, Phase II
Updated: 12/31/1969
2189
mi
from 91732
Chapel Hill, NC
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Study of Azacitidine in Combination With Pembrolizumab in Relapsed/Refractory Acute Myeloid Leukemia (AML) Patients and in Newly Diagnosed Older (≥65 Years) AML Patients
Status: Enrolling, Phase II
Updated: 12/31/1969
2184
mi
from 91732
Charleston, SC
Click here to add this to my saved trials
Cannabis Intoxication Clinical Trial
Using a Field Performance Test on an iPad to Evaluate Driving Under the Influence of Cannabis
Status: Enrolling, Phase II, III
Updated: 5/1/2018
106
mi
from 91732
San Diego, CA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Safety, Tolerability, Pharmacokinetics and Activity of K0706
Status: Enrolling, Phase I, II
Updated: 12/31/1969
1224
mi
from 91732
Dallas, TX
Click here to add this to my saved trials
Neurology, Orthopedics / Podiatry Clinical Trial
Blepharospasm Tools
Status: Enrolling, Phase
Updated: 12/31/1969
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Hypoplastic Left Heart Syndrome (HLHS) Clinical Trial
National Collaborative to Improve Care of Children With Complex Congenital Heart Disease
Status: Enrolling, Phase
Updated: 4/9/2018
1784
mi
from 91732
Birmingham, AL
Click here to add this to my saved trials
Hypoplastic Left Heart Syndrome (HLHS) Clinical Trial
National Collaborative to Improve Care of Children With Complex Congenital Heart Disease
Status: Enrolling, Phase
Updated: 4/9/2018
2316
mi
from 91732
Miami, FL
Click here to add this to my saved trials
Hypoplastic Left Heart Syndrome (HLHS) Clinical Trial
National Collaborative to Improve Care of Children With Complex Congenital Heart Disease
Status: Enrolling, Phase
Updated: 4/9/2018
2434
mi
from 91732
New York, NY
Click here to add this to my saved trials
Hypoplastic Left Heart Syndrome (HLHS) Clinical Trial
National Collaborative to Improve Care of Children With Complex Congenital Heart Disease
Status: Enrolling, Phase
Updated: 4/9/2018
826
mi
from 91732
Portland, OR
Click here to add this to my saved trials
Hypoplastic Left Heart Syndrome (HLHS) Clinical Trial
National Collaborative to Improve Care of Children With Complex Congenital Heart Disease
Status: Enrolling, Phase
Updated: 4/9/2018
1569
mi
from 91732
Saint Louis, MO
Click here to add this to my saved trials
Carcinoma Breast Stage IV Clinical Trial
A Study of Pembrolizumab With Carboplatin and Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
1654
mi
from 91732
Madison, WI
Click here to add this to my saved trials
Bacterial Infections Clinical Trial
Dose-finding, Pharmacokinetics, and Safety of VABOMERE in Pediatric Subjects With Bacterial Infections
Status: Enrolling, Phase I
Updated: 12/31/1969
2036
mi
from 91732
Cleveland, OH
Click here to add this to my saved trials
Bacterial Infections Clinical Trial
Dose-finding, Pharmacokinetics, and Safety of VABOMERE in Pediatric Subjects With Bacterial Infections
Status: Enrolling, Phase I
Updated: 12/31/1969
21
mi
from 91732
Orange, CA
Click here to add this to my saved trials
Bacterial Infections Clinical Trial
Dose-finding, Pharmacokinetics, and Safety of VABOMERE in Pediatric Subjects With Bacterial Infections
Status: Enrolling, Phase I
Updated: 12/31/1969
22
mi
from 91732
Torrance, CA
Click here to add this to my saved trials
Hepatocellular Carcinoma Clinical Trial
Study of Pembrolizumab (MK-3475) as Monotherapy in Participants With Advanced Hepatocellular Carcinoma (MK-3475-224/KEYNOTE-224)
Status: Enrolling, Phase II
Updated: 12/31/1969
2126
mi
from 91732
Winston-Salem, NC
Click here to add this to my saved trials
Triple Negative Breast Cancer (TNBC) Clinical Trial
Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs. Placebo Plus Chemotherapy for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer (MK-3475-355/KEYNOTE-355)
Status: Enrolling, Phase III
Updated: 4/26/2018
1922
mi
from 91732
Atlanta, GA
Click here to add this to my saved trials
Triple Negative Breast Cancer (TNBC) Clinical Trial
Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs. Placebo Plus Chemotherapy for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer (MK-3475-355/KEYNOTE-355)
Status: Enrolling, Phase III
Updated: 4/26/2018
2577
mi
from 91732
Boston, MA
Click here to add this to my saved trials
Triple Negative Breast Cancer (TNBC) Clinical Trial
Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs. Placebo Plus Chemotherapy for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer (MK-3475-355/KEYNOTE-355)
Status: Enrolling, Phase III
Updated: 4/26/2018
2183
mi
from 91732
Charleston, SC
Click here to add this to my saved trials
Triple Negative Breast Cancer (TNBC) Clinical Trial
Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs. Placebo Plus Chemotherapy for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer (MK-3475-355/KEYNOTE-355)
Status: Enrolling, Phase III
Updated: 4/26/2018
1726
mi
from 91732
Chicago, IL
Click here to add this to my saved trials
Triple Negative Breast Cancer (TNBC) Clinical Trial
Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs. Placebo Plus Chemotherapy for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer (MK-3475-355/KEYNOTE-355)
Status: Enrolling, Phase III
Updated: 4/26/2018
1400
mi
from 91732
Fargo, ND
Click here to add this to my saved trials
Triple Negative Breast Cancer (TNBC) Clinical Trial
Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs. Placebo Plus Chemotherapy for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer (MK-3475-355/KEYNOTE-355)
Status: Enrolling, Phase III
Updated: 4/26/2018
11
mi
from 91732
Los Angeles, CA
Click here to add this to my saved trials
Triple Negative Breast Cancer (TNBC) Clinical Trial
Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs. Placebo Plus Chemotherapy for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer (MK-3475-355/KEYNOTE-355)
Status: Enrolling, Phase III
Updated: 4/26/2018
1818
mi
from 91732
Louisville, KY
Click here to add this to my saved trials
Triple Negative Breast Cancer (TNBC) Clinical Trial
Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs. Placebo Plus Chemotherapy for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer (MK-3475-355/KEYNOTE-355)
Status: Enrolling, Phase III
Updated: 4/26/2018
1726
mi
from 91732
Skokie, IL
Click here to add this to my saved trials
Triple Negative Breast Cancer (TNBC) Clinical Trial
Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs. Placebo Plus Chemotherapy for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer (MK-3475-355/KEYNOTE-355)
Status: Enrolling, Phase III
Updated: 4/26/2018
8
mi
from 91732
Whittier, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Olaparib With or Without Atezolizumab in Treating Patients With Locally Advanced or Metastatic Non-HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
825
mi
from 91732
Aurora, CO
Click here to add this to my saved trials
Oncology Clinical Trial
Olaparib With or Without Atezolizumab in Treating Patients With Locally Advanced or Metastatic Non-HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
2578
mi
from 91732
Boston, MA
Click here to add this to my saved trials
Oncology Clinical Trial
Olaparib With or Without Atezolizumab in Treating Patients With Locally Advanced or Metastatic Non-HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
1959
mi
from 91732
Columbus, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Olaparib With or Without Atezolizumab in Treating Patients With Locally Advanced or Metastatic Non-HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
2468
mi
from 91732
Fairfield, CT
Click here to add this to my saved trials
Oncology Clinical Trial
Olaparib With or Without Atezolizumab in Treating Patients With Locally Advanced or Metastatic Non-HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
1952
mi
from 91732
Farmington Hills, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Olaparib With or Without Atezolizumab in Treating Patients With Locally Advanced or Metastatic Non-HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
95
mi
from 91732
La Jolla, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Olaparib With or Without Atezolizumab in Treating Patients With Locally Advanced or Metastatic Non-HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
2486
mi
from 91732
New Haven, CT
Click here to add this to my saved trials
Oncology Clinical Trial
Olaparib With or Without Atezolizumab in Treating Patients With Locally Advanced or Metastatic Non-HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
1569
mi
from 91732
Saint Louis, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Olaparib With or Without Atezolizumab in Treating Patients With Locally Advanced or Metastatic Non-HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
573
mi
from 91732
Salt Lake City, UT
Click here to add this to my saved trials
Oncology Clinical Trial
Olaparib With or Without Atezolizumab in Treating Patients With Locally Advanced or Metastatic Non-HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
356
mi
from 91732
Scottsdale, AZ
Click here to add this to my saved trials
Oncology Clinical Trial
Olaparib With or Without Atezolizumab in Treating Patients With Locally Advanced or Metastatic Non-HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
2134
mi
from 91732
Tampa, FL
Click here to add this to my saved trials
Schizophrenia Clinical Trial
Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia
Status: Enrolling, Phase II
Updated: 12/31/1969
2447
mi
from 91732
Cedarhurst, NY
Click here to add this to my saved trials
Schizophrenia Clinical Trial
Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia
Status: Enrolling, Phase II
Updated: 12/31/1969
1471
mi
from 91732
Lake Charles, LA
Click here to add this to my saved trials
Schizophrenia Clinical Trial
Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia
Status: Enrolling, Phase II
Updated: 12/31/1969
2314
mi
from 91732
Miami, FL
Click here to add this to my saved trials
Schizophrenia Clinical Trial
Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia
Status: Enrolling, Phase II
Updated: 12/31/1969
7
mi
from 91732
Pico Rivera, CA
Click here to add this to my saved trials
Neurological Observations Clinical Trial
Additional Post Hoc Analysis and Clinical Data Collection
Status: Enrolling
Updated: 1/15/2018
1254
mi
from 91732
Lincoln, NE
Click here to add this to my saved trials
Lymphoma Clinical Trial
Study of ACTR087 in Subjects With Relapsed or Refractory B-cell Lymphoma
Status: Enrolling, Phase I
Updated: 12/31/1969
1959
mi
from 91732
Columbus, OH
Click here to add this to my saved trials
Lymphoma Clinical Trial
Study of ACTR087 in Subjects With Relapsed or Refractory B-cell Lymphoma
Status: Enrolling, Phase I
Updated: 12/31/1969
361
mi
from 91732
Gilbert, AZ
Click here to add this to my saved trials
Oncology Clinical Trial
CB-839 + Capecitabine in Solid Tumors and Fluoropyrimidine Resistant PIK3CA Mutant Colorectal Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
2036
mi
from 91732
Cleveland, OH
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Phase II Randomized Trial of mFOLFIRINOX +/- Ramucirumab in Advanced Pancreatic Cancer
Status: Enrolling, Phase II
Updated: 4/23/2018
1922
mi
from 91732
Atlanta, GA
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Phase II Randomized Trial of mFOLFIRINOX +/- Ramucirumab in Advanced Pancreatic Cancer
Status: Enrolling, Phase II
Updated: 4/23/2018
2266
mi
from 91732
Gettysburg, PA
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Phase II Randomized Trial of mFOLFIRINOX +/- Ramucirumab in Advanced Pancreatic Cancer
Status: Enrolling, Phase II
Updated: 4/23/2018
1295
mi
from 91732
Omaha, NE
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Phase II Randomized Trial of mFOLFIRINOX +/- Ramucirumab in Advanced Pancreatic Cancer
Status: Enrolling, Phase II
Updated: 4/23/2018
2375
mi
from 91732
Philadelphia, PA
Click here to add this to my saved trials
Musculoskeletal Clinical Trial
IN Ketamine Vs IN Midazolam and Fentanyl for Abscess I&D
Status: Enrolling, Phase IV
Updated: 8/10/2016
1586
mi
from 91732
Memphis, TN
Click here to add this to my saved trials
Restless Legs Syndrome (RLS) Clinical Trial
Randomized, Placebo-controlled Trial of Ferric Carboxymaltose in RLS Patients With Iron-deficiency Anemia
Status: Enrolling, Phase II
Updated: 12/31/1969
2304
mi
from 91732
Baltimore, MD
Click here to add this to my saved trials
Restless Legs Syndrome (RLS) Clinical Trial
Randomized, Placebo-controlled Trial of Ferric Carboxymaltose in RLS Patients With Iron-deficiency Anemia
Status: Enrolling, Phase II
Updated: 12/31/1969
961
mi
from 91732
Seattle, WA
Click here to add this to my saved trials
Diabetes Clinical Trial
Glycemic Response to Three Oral Nutrition Supplements in Persons With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 8/10/2016
25
mi
from 91732
Tustin, CA
Click here to add this to my saved trials
Keratolysis Clinical Trial
Vision Restoration With a Collagen Crosslinked Boston Keratoprosthesis Unit
Status: Enrolling, Phase I, II
Updated: 12/31/1969
13
mi
from 91732
Los Angeles, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Rebastinib Plus Antitubulin Therapy With Paclitaxel or Eribulin in Metastatic Breast Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
2438
mi
from 91732
Bronx, NY
Click here to add this to my saved trials
Type 1 Diabetes Mellitus Clinical Trial
Bigfoot Biomedical Clinical Research Center (CRC) Trial
Status: Enrolling, Phase I
Updated: 8/11/2016
824
mi
from 91732
Aurora, CO
Click here to add this to my saved trials
Type 1 Diabetes Mellitus Clinical Trial
Bigfoot Biomedical Clinical Research Center (CRC) Trial
Status: Enrolling, Phase I
Updated: 8/11/2016
328
mi
from 91732
Stanford, CA
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
2181
mi
from 91732
Buffalo, NY
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
2468
mi
from 91732
Burlington, VT
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
2207
mi
from 91732
Charlottesville, VA
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
2036
mi
from 91732
Cleveland, OH
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
21
mi
from 91732
Orange, CA
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
2121
mi
from 91732
Pittsburgh, PA
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
1931
mi
from 91732
Ann Arbor, MI
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
2102
mi
from 91732
Charlotte, NC
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
1966
mi
from 91732
Detroit, MI
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
1663
mi
from 91732
Effingham, IL
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
690
mi
from 91732
El Paso, TX
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
31
mi
from 91732
Fontana, CA
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
2290
mi
from 91732
Greenville, NC
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
2022
mi
from 91732
Greenville, SC
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
819
mi
from 91732
Honolulu, HI
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
1528
mi
from 91732
Iowa City, IA
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
1925
mi
from 91732
Knoxville, TN
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
2407
mi
from 91732
Morristown, NJ
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
1653
mi
from 91732
New Orleans, LA
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
2184
mi
from 91732
Orlando, FL
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
328
mi
from 91732
Palo Alto, CA
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
1569
mi
from 91732
Saint Louis, MO
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
102
mi
from 91732
San Diego, CA
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
964
mi
from 91732
Seattle, WA
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
939
mi
from 91732
Spokane, WA
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
2322
mi
from 91732
Syracuse, NY
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
2281
mi
from 91732
Washington DC,
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Gastroenterology, Musculoskeletal, Psychiatry / Psychology, Pulmonary / Respiratory Diseases, Rheumatology Clinical Trial
Integrating Behavioral Health and Primary Care for Comorbid Behavioral and Medical Problems
Status: Enrolling
Updated: 1/10/2018
2468
mi
from 91732
Burlington, VT
Click here to add this to my saved trials
Gastroenterology Clinical Trial
SOFEED: Six Food vs. One Food Eosinophilic Esophagitis Diet Study
Status: Enrolling, Phase II, III
Updated: 1/25/2018
2189
mi
from 91732
Chapel Hill, NC
Click here to add this to my saved trials
Gastroenterology Clinical Trial
SOFEED: Six Food vs. One Food Eosinophilic Esophagitis Diet Study
Status: Enrolling, Phase II, III
Updated: 1/25/2018
1880
mi
from 91732
Cincinnati, OH
Click here to add this to my saved trials
Gastroenterology Clinical Trial
SOFEED: Six Food vs. One Food Eosinophilic Esophagitis Diet Study
Status: Enrolling, Phase II, III
Updated: 1/25/2018
1730
mi
from 91732
Chicago, IL
Click here to add this to my saved trials
Adenomyosis Clinical Trial
Placebo-controlled Proof of Concept Study of Epelsiban in Women With Adenomyosis
Status: Enrolling, Phase II
Updated: 8/16/2016
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Adenomyosis Clinical Trial
Placebo-controlled Proof of Concept Study of Epelsiban in Women With Adenomyosis
Status: Enrolling, Phase II
Updated: 8/16/2016
2301
mi
from 91732
West Palm Beach, FL
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
Status: Enrolling, Phase III
Updated: 12/31/1969
2433
mi
from 91732
Poughkeepsie, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
Status: Enrolling, Phase III
Updated: 12/31/1969
1727
mi
from 91732
Racine, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
Status: Enrolling, Phase III
Updated: 12/31/1969
2426
mi
from 91732
Ridgewood, NJ
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
Status: Enrolling, Phase III
Updated: 12/31/1969
2672
mi
from 91732
Rockport, ME
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
Status: Enrolling, Phase III
Updated: 12/31/1969
1973
mi
from 91732
Roseville, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
Status: Enrolling, Phase III
Updated: 12/31/1969
1962
mi
from 91732
Royal Oak, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
Status: Enrolling, Phase III
Updated: 12/31/1969
1962
mi
from 91732
Royal Oak, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
Status: Enrolling, Phase III
Updated: 12/31/1969
364
mi
from 91732
Sacramento, CA
Click here to add this to my saved trials